Clinical Trial Update: Intranasal SB-705498 in Allergic Rhinitis (AR) Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intranasal SB-705498 in allergic rhinitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• SB-705498

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2019-09-13